These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 10586049

  • 1. Ability of a nondepleting anti-CD4 antibody to inhibit Th2 responses and allergic lung inflammation is independent of coreceptor function.
    Li L, Crowley M, Nguyen A, Lo D.
    J Immunol; 1999 Dec 15; 163(12):6557-66. PubMed ID: 10586049
    [Abstract] [Full Text] [Related]

  • 2. CD4-mediated signals induce T cell dysfunction in vivo.
    Chirmule N, Avots A, LakshmiTamma SM, Pahwa S, Serfling E.
    J Immunol; 1999 Jul 15; 163(2):644-9. PubMed ID: 10395653
    [Abstract] [Full Text] [Related]

  • 3. Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses.
    Wang M, Ellison CA, Gartner JG, HayGlass KT.
    J Immunol; 1998 Feb 01; 160(3):1098-105. PubMed ID: 9570522
    [Abstract] [Full Text] [Related]

  • 4. Antigen-sensitized CD4+CD62Llow memory/effector T helper 2 cells can induce airway hyperresponsiveness in an antigen free setting.
    Nakagome K, Dohi M, Okunishi K, To Y, Sato A, Komagata Y, Nagatani K, Tanaka R, Yamamoto K.
    Respir Res; 2005 May 28; 6(1):46. PubMed ID: 15921525
    [Abstract] [Full Text] [Related]

  • 5. IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine.
    Nakagome K, Okunishi K, Imamura M, Harada H, Matsumoto T, Tanaka R, Miyazaki J, Yamamoto K, Dohi M.
    J Immunol; 2009 Jul 01; 183(1):209-20. PubMed ID: 19542432
    [Abstract] [Full Text] [Related]

  • 6. Induction of immune tolerance during administration of monoclonal antibody to L3T4 does not depend on depletion of L3T4+ cells.
    Carteron NL, Wofsy D, Seaman WE.
    J Immunol; 1988 Feb 01; 140(3):713-6. PubMed ID: 2448372
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Th2-induced eotaxin expression and eosinophilia coexist with Th1 responses at the effector stage of lung inflammation.
    Li L, Xia Y, Nguyen A, Feng L, Lo D.
    J Immunol; 1998 Sep 15; 161(6):3128-35. PubMed ID: 9743380
    [Abstract] [Full Text] [Related]

  • 9. Calcium channel blocker prevents T helper type 2 cell-mediated airway inflammation.
    Gomes B, Cabral MD, Gallard A, Savignac M, Paulet P, Druet P, Mariamé B, Moreau M, Leclerc C, Guéry JC, Pelletier L.
    Am J Respir Crit Care Med; 2007 Jun 01; 175(11):1117-24. PubMed ID: 17347497
    [Abstract] [Full Text] [Related]

  • 10. Differential susceptibility of naïve versus cloned CD4+ T cells to antigen-specific and MHC-restricted anergy induction.
    Liu QS, Zhang RH, Chu YW, Xiong SD.
    Sheng Li Xue Bao; 2003 Dec 25; 55(6):633-40. PubMed ID: 14695478
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
    Denfeld RW, Hara H, Tesmann JP, Martin S, Simon JC.
    J Leukoc Biol; 2001 Apr 25; 69(4):548-54. PubMed ID: 11310840
    [Abstract] [Full Text] [Related]

  • 13. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.
    Takeshita K, Yamasaki T, Akira S, Gantner F, Bacon KB.
    Int Immunol; 2004 May 25; 16(5):685-95. PubMed ID: 15096484
    [Abstract] [Full Text] [Related]

  • 14. Schnurri-2 regulates Th2-dependent airway inflammation and airway hyperresponsiveness.
    Iwamura C, Kimura MY, Shinoda K, Endo Y, Hasegawa A, Yamashita M, Nakayama T.
    Int Immunol; 2007 Jun 25; 19(6):755-62. PubMed ID: 17493960
    [Abstract] [Full Text] [Related]

  • 15. The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model.
    Tamura T, Ariga H, Kinashi T, Uehara S, Kikuchi T, Nakada M, Tokunaga T, Xu W, Kariyone A, Saito T, Kitamura T, Maxwell G, Takaki S, Takatsu K.
    Int Immunol; 2004 Dec 25; 16(12):1691-9. PubMed ID: 15477229
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of T cell activation through down-regulation of TCR-CD3 expression mediated by an anti-CD90 Ab.
    Nishida E, Chen C, Morita A, Shimizu J.
    Immunol Lett; 2011 May 25; 136(2):163-70. PubMed ID: 21256162
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of an in vitro CD4+ T cell alloresponse using altered peptide ligands.
    Daniel C, Grakoui A, Allen PM.
    J Immunol; 1998 Apr 01; 160(7):3244-50. PubMed ID: 9531280
    [Abstract] [Full Text] [Related]

  • 19. Distinct biochemical signals characterize agonist- and altered peptide ligand-induced differentiation of naive CD4+ T cells into Th1 and Th2 subsets.
    Boutin Y, Leitenberg D, Tao X, Bottomly K.
    J Immunol; 1997 Dec 15; 159(12):5802-9. PubMed ID: 9550376
    [Abstract] [Full Text] [Related]

  • 20. SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo.
    Hou LF, He SJ, Wang JX, Yang Y, Zhu FH, Zhou Y, He PL, Zhang Y, Yang YF, Li Y, Tang W, Zuo JP.
    Int Immunopharmacol; 2009 Dec 15; 9(13-14):1509-17. PubMed ID: 19772931
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.